Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 1
1978 1
1984 1
1986 3
1989 2
1990 1
1991 2
1995 4
1996 5
1997 2
1998 4
1999 3
2000 8
2001 12
2002 11
2003 21
2004 21
2005 43
2006 39
2007 50
2008 51
2009 53
2010 53
2011 68
2012 91
2013 111
2014 113
2015 121
2016 128
2017 164
2018 188
2019 172
2020 213
2021 290
2022 310
2023 286
2024 144

Text availability

Article attribute

Article type

Publication date

Search Results

2,397 results

Results by year

Filters applied: . Clear all
Page 1
Systemic immune-inflammation index is associated with hepatic steatosis: Evidence from NHANES 2015-2018.
Song Y, Guo W, Li Z, Guo D, Li Z, Li Y. Song Y, et al. Front Immunol. 2022 Nov 18;13:1058779. doi: 10.3389/fimmu.2022.1058779. eCollection 2022. Front Immunol. 2022. PMID: 36466832 Free PMC article.
Hepatic steatosis was evaluated with heaptic steatosis index (HSI). ...To explore the potential relationship between SII, bariatric surgery and hepatic steatosis by controlling potential confounders by propensity score matching. ...
Hepatic steatosis was evaluated with heaptic steatosis index (HSI). ...To explore the potential relationship between SII, bari …
Hepatic Complications of Anorexia Nervosa.
Rosen E, Bakshi N, Watters A, Rosen HR, Mehler PS. Rosen E, et al. Dig Dis Sci. 2017 Nov;62(11):2977-2981. doi: 10.1007/s10620-017-4766-9. Epub 2017 Sep 20. Dig Dis Sci. 2017. PMID: 28932925 Review.
Liver enzymes may also less commonly increase as part of the refeeding process due to hepatic steatosis and can be distinguished from starvation hepatitis by the finding of a fatty liver on ultrasonography. ...
Liver enzymes may also less commonly increase as part of the refeeding process due to hepatic steatosis and can be distinguish …
Associations between alcohol consumption and hepatic steatosis in the USA.
Niezen S, Trivedi HD, Mukamal KJ, Jiang ZG. Niezen S, et al. Liver Int. 2021 Sep;41(9):2020-2023. doi: 10.1111/liv.15020. Epub 2021 Aug 5. Liver Int. 2021. PMID: 34297882 Free PMC article.
Despite being widely recognized as a common cause of fatty liver, the exact impact of alcohol consumption on hepatic steatosis in the general population is elusive. The recent National Health and Nutrition Examination Survey (NHANES) allowed us to examine this relat …
Despite being widely recognized as a common cause of fatty liver, the exact impact of alcohol consumption on hepatic steatosis …
Associations between life's essential 8 and non-alcoholic fatty liver disease among US adults.
Wang L, Yi J, Guo X, Ren X. Wang L, et al. J Transl Med. 2022 Dec 23;20(1):616. doi: 10.1186/s12967-022-03839-0. J Transl Med. 2022. PMID: 36564799 Free PMC article.
NAFLD was determined by transient elastography measured hepatic steatosis in the absence of other liver diseases and excess alcohol use. ...RESULTS: Among 3588 participants included (weighted mean age, 48.0 years; 95% confidence interval [CI] 46.4-49.7 years), 1839 …
NAFLD was determined by transient elastography measured hepatic steatosis in the absence of other liver diseases and excess al …
Liver fibrosis markers of nonalcoholic steatohepatitis.
Enomoto H, Bando Y, Nakamura H, Nishiguchi S, Koga M. Enomoto H, et al. World J Gastroenterol. 2015 Jun 28;21(24):7427-35. doi: 10.3748/wjg.v21.i24.7427. World J Gastroenterol. 2015. PMID: 26139988 Free PMC article. Review.
NAFLD includes a wide range of clinical conditions from simple steatosis to nonalcoholic steatohepatitis (NASH), advanced fibrosis, and liver cirrhosis. The histological findings of NASH indicate hepatic steatosis and inflammation with characteristic hepatocyte inju …
NAFLD includes a wide range of clinical conditions from simple steatosis to nonalcoholic steatohepatitis (NASH), advanced fibrosis, and live …
Design and validation of a histological scoring system for nonalcoholic fatty liver disease.
Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ; Nonalcoholic Steatohepatitis Clinical Research Network. Kleiner DE, et al. Hepatology. 2005 Jun;41(6):1313-21. doi: 10.1002/hep.20701. Hepatology. 2005. PMID: 15915461
Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis in the absence of a history of significant alcohol use or other known liver disease. ...The Pathology Committee of the NASH Clinical Research Network designed and validated a histological …
Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis in the absence of a history of significant alco …
The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population.
Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. Bedogni G, et al. BMC Gastroenterol. 2006 Nov 2;6:33. doi: 10.1186/1471-230X-6-33. BMC Gastroenterol. 2006. PMID: 17081293 Free PMC article.
We used data from the Dionysos Nutrition & Liver Study to develop a simple algorithm for the prediction of FL in the general population. METHODS: 216 subjects with and 280 without suspected liver disease were studied. ...Potential predictors were entered into st …
We used data from the Dionysos Nutrition & Liver Study to develop a simple algorithm for the prediction of FL in the general popu …
Activation of thyroid hormone receptor-β improved disease activity and metabolism independent of body weight in a mouse model of non-alcoholic steatohepatitis and fibrosis.
Kannt A, Wohlfart P, Madsen AN, Veidal SS, Feigh M, Schmoll D. Kannt A, et al. Br J Pharmacol. 2021 Jun;178(12):2412-2423. doi: 10.1111/bph.15427. Epub 2021 Apr 6. Br J Pharmacol. 2021. PMID: 33655500 Free article.
In patients with non-alcoholic steatohepatitis (NASH), treatment with THR-beta agonists decreased hepatic steatosis and circulating lipids, and induced resolution of NASH. ...KEY RESULTS: Treatment with resmetirom did not influence body weight but led to significant …
In patients with non-alcoholic steatohepatitis (NASH), treatment with THR-beta agonists decreased hepatic steatosis and circul …
Comprehensive Metabolic Phenotyping Refines Cardiovascular Risk in Young Adults.
Murthy VL, Reis JP, Pico AR, Kitchen R, Lima JAC, Lloyd-Jones D, Allen NB, Carnethon M, Lewis GD, Nayor M, Vasan RS, Freedman JE, Clish CB, Shah RV. Murthy VL, et al. Circulation. 2020 Dec;142(22):2110-2127. doi: 10.1161/CIRCULATIONAHA.120.047689. Epub 2020 Oct 19. Circulation. 2020. PMID: 33073606 Free PMC article.
RESULTS: In the CARDIA study, metabolite profiles quantified in early adulthood were associated with subclinical CVD development over 20 years, specifying known and novel pathways of CVD (eg, transcriptional regulation, brain-derived neurotrophic factor, nitric oxide, renin-angio …
RESULTS: In the CARDIA study, metabolite profiles quantified in early adulthood were associated with subclinical CVD development over 20 yea …
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease.
Lin H, Lee HW, Yip TC, Tsochatzis E, Petta S, Bugianesi E, Yoneda M, Zheng MH, Hagström H, Boursier J, Calleja JL, Goh GB, Chan WK, Gallego-Durán R, Sanyal AJ, de Lédinghen V, Newsome PN, Fan JG, Castéra L, Lai M, Harrison SA, Fournier-Poizat C, Wong GL, Pennisi G, Armandi A, Nakajima A, Liu WY, Shang Y, de Saint-Loup M, Llop E, Teh KK, Lara-Romero C, Asgharpour A, Mahgoub S, Chan MS, Canivet CM, Romero-Gomez M, Kim SU, Wong VW; VCTE-Prognosis Study Group. Lin H, et al. JAMA. 2024 Apr 16;331(15):1287-1297. doi: 10.1001/jama.2024.1447. JAMA. 2024. PMID: 38512249
At a median follow-up of 51.7 (IQR, 25.2-85.2) months, 316 patients (1.9%) developed LREs. Both Agile 3+ and Agile 4 scores classified fewer patients between the low and high cutoffs than most fibrosis scores and achieved the highest discriminatory power in predi …
At a median follow-up of 51.7 (IQR, 25.2-85.2) months, 316 patients (1.9%) developed LREs. Both Agile 3+ and Agile 4 scores classifie …
2,397 results